April 9 (Reuters) - Illumina ( ILMN ) said on Tuesday

Chief Financial Officer Joydeep Goswami would leave the gene

sequencing company and would be succeeded by former Summit

Therapeutics' executive Ankur Dhingra.

Goswami, who has more than two decades of experience in the

life sciences industry, was the CFO since early 2023 and will

serve as an adviser till June 30, the company said.

Illumina ( ILMN ) has also reaffirmed its forecast for the first

quarter and full-year 2024.